RANDA CORLEY: Open Payments
NPI 1144946245 · REFORM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 6 companies in 2025. Trend: 2023 $993 · 2024 $572 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| ABBVIE INC. | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 1 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lilly USA, LLC | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: Wegovy, FANAPT, CAPLYTA, MOUNJARO, UBRELVY, Ozempic, LINZESS, INGREZZA.
Industry payments across AL — which companies pay providers there.
